Cited by 204Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

Open access

Hart, Robert G., Pearce, Lesly A., Asinger, Richard W., Herzog, Charles A.·2011·Clinical Journal of the American Society of Nephrology

DOI 10.2215/cjn.02400311PMC PMC3359566

Open this paper in CoChat — free account

Abstract

BACKGROUND AND OBJECTIVES: The efficacy of adjusted-dose warfarin for prevention of stroke in atrial fibrillation patients with stage 3 chronic kidney disease (CKD) is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with stage 3 CKD participating in the Stroke Prevention in Atrial Fibrillation 3 trials were assessed to determine the effect of warfarin anticoagulation on stroke and major hemorrhage, and whether CKD status independently contributed to stroke risk. High-risk participants (n = 1044) in the randomized trial were assigned to adjusted-dose warfarin (target international normalized ratio 2 to 3) versus aspirin (325 mg) plus fixed, low-dose warfarin (subsequently shown to be equivalent to aspirin alone). Low-risk participants (n = 892) all received 325 mg aspirin daily. The primary outcome was ischemic stroke (96%) or systemic embolism (4%). RESULTS: Among the 1936 participants in the two trials, 42% (n = 805) had stage 3 CKD at entry. Considering the 1314 patients not assigned to adjusted-dose warfarin, the primary event rate was double among those with stage 3 CKD (hazard ratio 2.0, 95% CI 1.2, 3.3) versus those with a higher estimated GFR (eGFR). Among the 516 participants with stage 3 CKD included in the randomized trial, ischemic stroke/systemic embolism was reduced 76% (95% CI 42, 90; P < 0.001) by adjusted-dose warfarin compared with aspirin/low-dose warfarin; there was no difference in major hemorrhage (5 patients versus 6 patients, respectively). CONCLUSIONS: Among atrial fibrillation patients participating in the Stroke Prevention in Atrial Fibrillation III trials, stage 3 CKD was associated with higher rates of ischemic stroke/systemic embolism. Adjusted-dose warfarin markedly reduced ischemic stroke/systemic embolism in high-risk atrial fibrillation patients with stage 3 CKD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2215/cjn.02400311

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Self-citation
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
(2006) · The Lancet · doi:10.1016/s0140-6736(06)68845-4 · Cited by 1,952

Show all 28 references

Sorted by citations

Items 101–200 of 204

Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
Hohnloser, S. H., Steg, P. G., Oldgren, J., Nickenig, G., Kiss, R. G., Öngen, Z., Estrada, J. L. N., Ophuis, T. O., Lip, G. Y. H., Nordaby, M., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.05.050 · Cited by 14
CHRONIC KIDNEY DISEASE AND ARRHYTHMIAS: CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE
Blankestijn, P. J., Carrero, J. J., Clase, C. M., Deo, R., Herzog, C. A., Kasner, S. E., PASSMAN, R. S., Pecoits‐Filho, R., Reinecke, H., Shroff, G. R., et al. (2019) · Nephrology (Saint-Petersburg) · doi:10.24884/1561-6274-2019-23-2-18-40 · Cited by 13
Self-citation
Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019
Zhang, L., Steckman, D. A., ADELSTEIN, E. C., Schulman‐Marcus, J., Loka, A. M., Mathew, R. O., Venditti, F. J., & Sidhu, M. S. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06885-x · Cited by 13
Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care
Mongkhon, P., Alwafi, H. H., Fanning, L., Lau, W. C. Y., Wei, L., Kongkaew, C., & Wong, I. C. K. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14464 · Cited by 14
Renal Disease and Atrial Fibrillation
Stefil, M., Nabrdalik, K., & Lip, G. Y. H. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.001 · Cited by 13
Preoperative Cardiovascular Assessment of the Renal Transplant Recipient: A Narrative Review
Kotta, P. A., Elango, M., & Papalois, V. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112525 · Cited by 13
La anticoagulación oral en el anciano con fibrilación auricular no valvular
Fernández, F. V., Jiménez, M. D. R. M., Cerviño, S. M. B., & Losada, M. D. M. M. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2015.01.005 · Cited by 13
Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation
Chang, C., Chiu, P., Huang, C.-H., Chang, Y., Chang, C., Wu, C., & Liou, H. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s44242 · Cited by 12
Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review
Cases, A., Gómez, P., Broseta, J. J., Pérez-Bernat, E., Barrionuevo, J. D. D. A., Portolés, J. M., & Górriz, J. L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.654620 · Cited by 13
Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration
Yanagisawa, S., Inden, Y., Fujii, A., Ando, M., Funabiki, J., Murase, Y., Takenaka, M., Otake, N., Ikai, Y., Sakamoto, Y., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.033 · Cited by 13
Glomerular filtration rate and association to stroke, major bleeding, and death in patients with mechanical heart valve prosthesis
Labaf, A., Grzymala-Lubanski, B., Själander, A., Svensson, P. J., & Stagmo, M. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.06.016 · Cited by 10
Anticoagulation, atrial fibrillation, and chronic kidney disease—whose side are you on?
Heine, G. H., & Brandenburg, V. M. (2017) · Kidney International · doi:10.1016/j.kint.2016.11.028 · Cited by 11
2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
Lee, J., Joung, B., Cha, M., Lee, J. H., Lim, W., Kim, T., Shin, S. Y., Uhm, J., Lim, H. E., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.87.e1 · Cited by 11
Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease
Brimble, K. S., Ingram, A. J., Eikelboom, J. W., & Hart, R. G. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.11.2609 · Cited by 11
Self-citation
Atrial Fibrillation Management in Older Heart Failure Patients: A Complex Clinical Problem
Pulignano, G., Sindaco, D. D., Tinti, M. D., Tolone, S., Minardi, G., Lax, A., & Uguccioni, M. (2016) · Heart International · doi:10.5301/heartint.5000230 · Cited by 11
Antithrombotic agents: Platelet inhibitors, acute anticoagulants, fibrinolytics, and chronic anticoagulants
Fox, K. A. A., White, H. D., Gersh, B. J., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00018-1 · Cited by 9
Anti‐thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views
Ghadban, R., Flaker, G., Katta, N., & Alpert, M. (2017) · Hemodialysis International · doi:10.1111/hdi.12600 · Cited by 8
2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
Lee, J., Joung, B., Cha, M., Lee, J. H., Lim, W., Kim, T., Shin, S. Y., Uhm, J., Lim, H. E., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.87 · Cited by 8
Renal Function and Oral Anticoagulant Treatment of Incident non-valvular Atrial Fibrillation: A Retrospective Study
Ramagopalan, S. V., Stamp, E., Sammon, C., Besford, M., Carroll, R., Mehmud, F., & Alikhan, R. (2019) · Future Cardiology · doi:10.2217/fca-2019-0012 · Cited by 8
Clinical Interventions and All-Cause Mortality of Patients with Chronic Kidney Disease: An Umbrella Systematic Review of Meta-Analyses
Kim, J. Y., Steingroever, J., Lee, K. H., Oh, J. S., Choi, M., Lee, J. M., Larkins, N., Schaefer, F. S., Hong, S. H., Jeong, G. H., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020394 · Cited by 9
Background characteristics and anticoagulant usage patterns of elderly non-valvular atrial fibrillation patients in the ANAFIE registry: a prospective, multicentre, observational cohort study in Japan
Yasaka, M., Yamashita, T., Akao, M., Atarashi, H., Ikeda, T., Koretsune, Y., Okumura, K., Shimizu, W., Tsutsui, H., Toyoda, Ḱ., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044501 · Cited by 8
Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation
Dhaese, S. A. M., & Vriese, A. S. D. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.01.007 · Cited by 9
Warfarin in non-valvular atrial fibrillation
Dalby, A. J., Wessels, P., & Opie, L. H. (2013) · South African Medical Journal · doi:10.7196/samj.7172 · Cited by 8
Anticoagulación oral en la enfermedad renal crónica con fibrilación auricular
Gómez-Fernández, P., Santana, A. M., & Barrionuevo, J. D. D. A. (2020) · Nefrología · doi:10.1016/j.nefro.2020.08.007 · Cited by 7
Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
Zagidullin, N. S., & Davtyan, P. A. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4676 · Cited by 8
Selecting antithrombotic therapy for patients with atrial fibrillation
Tanaka‐Esposito, C., & Chung, M. K. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82a.140002 · Cited by 8
Oral anticoagulation in chronic kidney disease with atrial fibrillation
Expósito, V., Seras, M., & Fernández‐Fresnedo, G. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.12.013 · Cited by 7
Different types of atrial fibrillation, renal function, and mortality in elderly Chinese patients with coronary artery disease
Fu, S., Ye, P., Liu, T., & Luo, L. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s55972 · Cited by 6
Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation
Abrignani, M. G., Lombardo, A., Braschi, A., Renda, N., Abrignani, V., & Lombardo, R. M. (2022) · World Journal of Cardiology · doi:10.4330/wjc.v14.i11.576 · Cited by 6
Comparison of Stroke and Bleeding Risk Profile in Patients With Atrial Fibrillation and Chronic Kidney Disease
Barcía, J. A. P., Raposeiras‐Roubín, S., Abu-Assi, E., Erquicia, P. D., Castro, A. L., Lestón, L. R., Míguez, J. O., Bermúdez, I. G., & Íñiguez, A. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.03.018 · Cited by 7
Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses
Kılıçkap, M., Bosch, J., Eikelboom, J. W., & Hart, R. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.06.003 · Cited by 6
Self-citation
Implications of Kidney Disease in the Cardiac Patient
Nicolas, J., Claessen, B. E. P. M., & Mehran, R. (2020) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2020.03.002 · Cited by 6
Cardiovascular disease
Shah, A. P., Khoury, C. C., & Mehrotra, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47871-7.00030-7 · Cited by 5
Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin
Lau, Y. C., Xiong, Q., Lip, G. Y. H., & Blann, A. D. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1166516 · Cited by 5
Laboratory characteristics of ischemic stroke patients with atrial fibrillation on or off therapeutic warfarin
Aachi, V. R., Birnbaum, L., Topel, C. H., Seifi, A., Hafeez, S., & Behrouz, R. (2017) · Clinical Cardiology · doi:10.1002/clc.22838 · Cited by 5
Systematic Review and Meta-analysis of the Predictive Performance of Stroke and Bleeding Prediction Models in Atrial Fibrillation Patients With Kidney Disease
Langenhuijsen, L. F. S., Derksen, D. C. L., Milders, J., van der Horst, S. F. B., van Diepen, M., Trines, S. A. I. P., den Exter, P. L., Klok, F. A., Rotmans, J. I., & de Jong, Y. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101200 · Cited by 5
Management of Atrial Fibrillation in Patients With Kidney Disease.
Lau, Y. C., & Lip, G. Y. H. (2014) · PubMed Central · doi:10.4022/jafib.989 · Cited by 4
Necessity of Antiaggregation and Anticoagulation and Its Prognostic Impact: A Cardiologist’s View
Hink, U., & Voigtländer, T. (2020) · Visceral Medicine · doi:10.1159/000509896 · Cited by 5
Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations
Parks, A. L., Stevens, S. M., & Woller, S. C. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.109097 · Cited by 4
Cardiac Function and Cardiovascular Disease in Chronic Kidney Disease
Weiner, D. E., & Sarnak, M. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4617-0.00056-x · Cited by 3
Oral anticoagulation in chronic kidney disease: A huge challenge
Marín, F. R., & Roldán, V. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-05-0324 · Cited by 3
Anticoagulación oral en la enfermedad renal crónica con fibrilación auricular
Expósito, V., Seras, M., & Fernández‐Fresnedo, G. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.03.029 · Cited by 3
Warfarin therapy for atrial fibrillation in haemodialysis patients: mind the (evidence) gap
Szummer, K. E., & Carrero, J. J. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu412 · Cited by 3
Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
Garrick, R. E. (2012) · Yearbook of Medicine · doi:10.1016/j.ymed.2012.08.029 · Cited by 3
Neurologic Complications of Chronic Kidney Disease
Murray, A. M., Seliger, S. L., & Stendahl, J. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00021-4 · Cited by 3
2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up
Park, J., Kim, J., Baek, Y., Lee, S., Hwang, Y. M., Kim, T.-H., Lee, D. I., Lee, K. H., Shim, J., & Joung, B. (2019) · Korean Journal of Medicine · doi:10.3904/kjm.2019.94.1.17 · Cited by 3
Cardiovascular Disease and Chronic Kidney Disease
Parfrey, P. S., & Barrett, B. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00016-0 · Cited by 3
Oral Anticoagulant Use in Patients With Chronic Kidney Disease: How to Choose, and the Importance of Empiric Human Data
Witt, C. T., & Healey, J. S. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.06.006 · Cited by 3
Society Guidelines 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Verma, A., Cairns, J. A., Mitchell, L. B., Macle, L., Stiell, I. G., Gladstone, D. J., McMurtry, M. S., Connolly, S. J., Cox, J. L., Dorian, P., et al. (2014) · Cited by 2
Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment
Lind, M. M., Jansson, J., Nilsson, T. K., Järvholm, L. S., & Johansson, L. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.06.011 · Cited by 2
Antikoagulation bei Patienten mit chronischer Niereninsuffizienz : Empfehlungen der Arbeitsgemeinschaft "Herz Niere" der Deutschen Gesellschaft für Kardiologie Herz- und Kreislaufforschung und der Deutschen Gesellschaft für Nephrologie.
Schlieper, G., Schwenger, V., Remppis, A. B., Keller, T., Dechend, R., Maßberg, S., Baldus, S. E., Weinreich, T., Hetzel, G. R., Floege, J., et al. (2017) · RWTH Publications (RWTH Aachen) · Cited by 2
Warfarin for Atrial Fibrillation Stroke Prophylaxis in Advanced Kidney Disease
Pun, P. H., Pokorney, S. D., & Granger, C. B. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.07.020 · Cited by 2
Cardiac Function and Cardiovascular Disease in Chronic Kidney Disease
Weiner, D. E., & Sarnak, M. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47794-9.00055-x · Cited by 1
Estimated glomerular filtration rate and the risk of stroke in individuals with diabetes mellitus and atrial fibrillation insight from a large contemporary population study
Westreich, R., Tsaban, G., Barrett, O., Kezerle, L., Tsadok, M. A., Akriv, A., Bachrach, A., Leventer‐Roberts, M., Senderey, A. B., & Haim, M. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02913-8 · Cited by 1
CHARACTERIZATION OF THE EFFECT OF CHRONIC KIDNEY DISEASE ON HEPATIC DRUG REDUCTION: IN-VITRO AND IN-VIVO STUDIES OF WARFARIN
Alshogran, O. Y. (2014) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Anticoagulation for Atrial Fibrillation in End-stage Kidney Disease
Lee, G., & Johnson, D. W. (2015) · Journal of Controversies in Biomedical Research · doi:10.15586/jcbmr.2015.9 · Cited by 1
Non-vitamin K antagonist oral anticoagulants for heart diseases
Борисовна, К. Т., Popova, L. V., & Николаевич, Б. И. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh2017899120-127 · Cited by 1
Stroke and Atrial Fibrillation in Chronic Kidney Disease and Dialysis
Collister, D., & Walsh, M. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55429-9.00014-5 · Cited by 2
Warfarin Dosing and Outcomes in Chronic Kidney Disease: A Closer Look at Warfarin Disposition
Alshogran, O. Y. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666190701095807 · Cited by 1
Neurologic Complications of Chronic Kidney Disease
Seliger, S. L., & Waddy, S. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00029-2 · Cited by 1
CKD-G 3–5: Antikoagulation bei Vorhofflimmern und Thromboembolien
Heine, G. H. (2023) · Die Nephrologie · doi:10.1007/s11560-023-00654-6 · Cited by 1
Anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: Arguments for or against
Komarovа, A. G., Lyakhova, N. L., Covanţev, S., Naryshkina, E. A., & Slepukhova, D. V. (2023) · Medical alphabet · doi:10.33667/2078-5631-2023-25-14-20 · Cited by 1
Use of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation According to Clinical Profile
Barrios, V., & Masjuán, J. (2016) · Future Cardiology · doi:10.2217/fca-2016-0061 · Cited by 1
Selección del tratamiento anticoagulante óptimo para el paciente con fibrilación auricular y diabetes o enfermedad renal crónica: papel del rivaroxabán
Cepeda, J. M., Arrarte, V., Fácila, L., Galvañ, V. G., Górriz, J. L., Trujillo‐Santos, J., & García, J. J. T. (2020) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30015-7 · Cited by 1
Oral anticoagulation in chronic kidney disease with atrial fibrillation
Fernández, P., Santana, A. M., & Barrionuevo, J. D. D. A. (2021) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2021.04.005 · Cited by 1
Secondary Prevention After Cardioembolic Stroke
Rubin, M. N., Freeman, W. D., & Aguilar, M. I. (2015) · Springer eBooks · doi:10.1007/978-3-319-17750-2_12 · Cited by 1
Warfarin, Atrial Fibrillation, and CKD: Effective and Safe, but Soon Extinct?
Larkin, J. W., & Chan, K. E. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.01.007 · Cited by 1
Patientenauswahl für die Implantation eines Vorhofohr-Okkluders in der Primär- und Sekundärprävention des kardioembolischen Schlaganfalls bei Vorhofflimmern
Israel, C. W., Ridjab, D. A., Tschishow, W. N., & Buddecke, J. (2013) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-013-0266-6
Does chronic kidney disease impact on cardiovascular complications and mortality in the elderly
Stompór, T. P., & Pankrac, K. (2013) · Postępy Nauk Medycznych
Can routinely collected primary care data determine the prevalence of chronic kidney disease and predict clinical events in patients with stages 3 of the disease
Jain, P. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Chronic kidney disease: One step further in the refinement of risk stratification of atrial fibrillation and impact on the choice of anticoagulant
Providencia, R. A., Ferreira, M. J., & Gonçalves, L. M. M. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.008
Determinants of adverse events during oral anticoagulant treatment
Lind, M. M. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Srce i krvni Sudovi
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Does chronic kidney disease impact on cardiovascular complications and mortality in the elderly? Czy przewlekła choroba nerek wpływa na występowanie chorób układu sercowo-naczyniowego i zgony z ich powodu u osób w wieku podeszłym?
Stompór, T. P., Pankrac, K., & Frankiewicz, D. (2013)
Summary of evidence-based guideline update: Preventionofstrokeinnonvalvularatrialfibrillation
Culebras, A., Messe, S. R., Chaturvedi, S., & Kase, C. S. (2014)
Anticoagulation in CKD
Quinn, K. M., Ingram, A. J., & Hart, R. G. (2014) · Springer eBooks · doi:10.1007/978-3-319-09162-4_4
Self-citation
CLINICAL PRACTICE Warfarin in non-valvular atrial fibrillation
Dalby, A. J., WESSELS, P. L., Haem, C. C., & Opie, L. H. (2013)
Evaluation of new oral anticoagulants in mild to moderate CKD patients with atrial fibrillation
Kiuchi, M. G., & Chen, S. (2016) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2016.11.009
Letter by Escobar et al Regarding Article, “On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF”
Escobar, C., Barrios, V., & Górriz, J. L. (2016) · Circulation · doi:10.1161/circulationaha.116.024514
Uaktualnienie praktycznego przewodnika EHRA dotyczącego stosowania doustnych antykoagulantów niebędących antagonistami witaminy K u pacjentów z niezastawkowym migotaniem przedsionków
Szymański, F. M. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0150
Upgrade system device in use of new oral anticoagulants vs. antiplatelet agents
Kiuchi, M. G., & Chen, S. (2017) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2017.06.006
Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease
Carlson, M. D., & Shroff, G. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-56042-7_27
Impacto de la anticoagulación y antiagregación plaquetaria en la anemia y los eventos hemorrágicos y ateroscleróticos de pacientes con enfermedad renal crónica en estadios 3 y 4
García‐Prieto, A., Goicoechea, M., Liñares, T., Panizo, N., de Vinuesa, M. S. G., Verdalles, Ú., Verde, E., de José, A. P., & Luño, J. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.01.021
Nicht-Vitamin-K-abhängige orale Antikoagulanzien (NOAK) bei chronischer Niereninsuffizienz
Schlieper, G., Remppis, A., Schwenger, V., Keller, T., Dechend, R., Maßberg, S., Baldus, S. E., Weinreich, T., Hetzel, G. R., Floege, J., et al. (2018) · Der Nephrologe · doi:10.1007/s11560-018-0230-x
Sollen ältere Patienten mit Vorhofflimmern auch bei fortgeschrittener Niereninsuffizienz antikoaguliert werden?
Hippe, H. (2018) · Der Nephrologe · doi:10.1007/s11560-018-0234-6
Anticoagulant therapy for patients with atrial fibrillationin in special situations: diabetes mellitus and/or chronic kidney disease
Кanorskiy, S. G. (2018) · Kardiologiia · doi:10.18087/cardio.2469
Impact of anticoagulation and platelet antiaggregation on anaemia and haemorrhagic events in patients with chronic kidney disease stages 3 and 4
García‐Prieto, A., Goicoechea, M., Liñares, T., Panizo, N., de Vinuesa, M. S. G., Verdalles, Ú., Verde, E., de José, A. P., & Luño, J. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.10.012
Paciente con alto riesgo cardiovascular y fibrilación auricular: papel del rivaroxabán
Barrios, V., Vivas, D., Atienza, F., Arias, M. A., Díaz‐Simón, R., Purificación, A. S., & Barón‐Esquivias, G. (2020) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30014-5
Anticoagulation control in patients with atrial fibrillation
Zulkifly, H. H. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
Herz und Niere
Marx, N., Floege, J., & Böhm, M. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-62939-0_10-1
ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: THE AXIS OF ROTATION BETWEEN THE POLES OF RISK
Kobalava, Z. D. K., & Анатольевич, Ш. А. (2018) · Eurasian heart journal · doi:10.38109/2225-1685-2018-2-64-82
Prevalence of Atrial Fibrillation in Patients With end Stage Renal Disease
Hawerroth, M. D. G. L., Sonoda, L. Y., Silva, J. J., & de Oliveira, W. A. (2023) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20220143
Antikoagulation und Thrombozytenaggregationshemmung bei chronischer Nierenkrankheit
Heine, G. H. (2023) · Springer eBooks · doi:10.1007/978-3-662-65648-8_29
CKD-G 3–5: Antikoagulation bei Vorhofflimmern und Thromboembolien
Heine, G. H. (2023) · Die Kardiologie · doi:10.1007/s12181-023-00633-0
Herz und Niere
Marx, N., Floege, J., & Böhm, M. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-62932-1_10
Secondary Prevention After Cardioembolic Stroke
Rubin, M. N., Klouda, E., & Lee, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-49963-0_17
Konsensuspapier zum Management kardiovaskulärer Erkrankungen bei chronischer Nierenkrankheit
Marx-Schütt, K., Kintscher, U., Dahm, J. B., Fliser, D., Heine, G. H., Hoyer, J. D., Jung, C., Mahfoud, F., Ott, I., Schlieper, G., et al. (2025) · Die Kardiologie · doi:10.1007/s12181-024-00716-6 · Cited by 1
Atrial Fibrillation in Advanced CKD
Ajmal, M. S., & Winkelmayer, W. C. (2025) · Kidney360 · doi:10.34067/kid.0000000869
Heart and Kidney
Marx, N., Floege, J., & Böhm, M. (2025) · Springer eBooks · doi:10.1007/978-3-662-69938-6_10
Atrial Fibrillation and Stroke Prevention and Management in CKD
Bansal, N., Charytan, D. M., Garg, A. X., Singer, D. E., Soliman, E. Z., Sood, M. M., Winkelmayer, W. C., & Go, A. S. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001159

Authors: Hart, R. G., Pearce, L. A., Asinger, R. W., & Herzog, C. A.
Affiliations: The University of Texas at San Antonio Health Science Center (US)
Hennepin County Medical Center (US)
Corresponding author: Hart, Robert G.
ORCID: Hart, Robert G.
Pearce, Lesly A.
Herzog, Charles A.
Venue: Clinical Journal of the American Society of Nephrology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-11
Volume: 6
Issue: 11
Pages: 2599-2604
ISSN: 1555-9041 (ISSN-L)
DOI: 10.2215/cjn.02400311
PMC: PMC3359566
OpenAlex: W2130977972
Cited by: 204
References: 28
Citations by year: 2026: 5 · 2025: 5 · 2024: 5 · 2023: 13 · 2022: 3 · 2021: 7 · 2020: 11 · 2019: 14 · 2018: 21 · 2017: 14 · 2016: 19 · 2015: 21 · 2014: 34 · 2013: 22 · 2012: 10
FWCI: 14.47
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Clinical Journal of the American Society of Nephrology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ns024224-11)
National Institute of Neurological Disorders and Stroke (R01NS24224)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: warfarin, atrial fibrillation, chronic kidney disease stage 3, stroke prevention, ischemic stroke, systemic embolism, major bleeding, aspirin, anticoagulation, estimated glomerular filtration rate
MeSH terms: Aged, Anticoagulants, Aspirin, Atrial Fibrillation, Blood Coagulation, Canada, Chronic Disease, Drug Therapy, Combination, Female, Hemorrhage, Humans, Kidney Diseases, Male, Platelet Aggregation Inhibitors, Risk Factors, Severity of Illness Index, Time Factors, United States, Warfarin, Chi-Square Distribution, Proportional Hazards Models, Treatment Outcome, Risk Assessment, International Normalized Ratio, Stroke, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks